当前位置:首页 - 行情中心 - 德源药业(920735) - 财务分析 - 现金流量表

德源药业

(920735)

  

流通市值:32.46亿  总市值:36.70亿
流通股本:1.14亿   总股本:1.29亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金277,324,279.171,063,419,134.48780,182,348.6494,325,261.84
  收到的税费返还-3,244,477.673,244,477.673,229,766.95
  收到其他与经营活动有关的现金8,220,622.2131,372,329.2626,758,997.195,526,885.68
  经营活动现金流入小计285,544,901.381,098,035,941.41810,185,823.46503,081,914.47
  购买商品、接受劳务支付的现金34,951,153.96149,673,660.59109,882,690.9771,056,197.06
  支付给职工以及为职工支付的现金60,812,279.36182,915,721.96139,396,996.1196,966,170.04
  支付的各项税费45,171,988.52142,858,246.9106,260,030.9677,457,079.61
  支付其他与经营活动有关的现金109,782,445.74465,921,228.07345,626,363.19228,460,653.08
  经营活动现金流出小计250,717,867.58941,368,857.52701,166,081.23473,940,099.79
  经营活动产生的现金流量净额34,827,033.8156,667,083.89109,019,742.2329,141,814.68
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,442,878.735,765,411.674,311,102.792,982,726.1
  处置固定资产、无形资产和其他长期资产收回的现金净额-9,856.318,6129,624.03
  收到的其他与投资活动有关的现金280,000,0001,860,600,0001,402,600,0001,082,600,000
  投资活动现金流入小计281,442,878.731,866,375,267.981,406,919,714.791,085,592,350.13
  购建固定资产、无形资产和其他长期资产支付的现金6,871,388.1853,224,934.5127,448,617.8119,122,192.22
  支付其他与投资活动有关的现金270,952,416.672,121,120,7501,661,120,7501,172,798,250
  投资活动现金流出小计277,823,804.852,174,345,684.511,688,569,367.811,191,920,442.22
  投资活动产生的现金流量净额3,619,073.88-307,970,416.53-281,649,653.02-106,328,092.09
三、筹资活动产生的现金流量:
  取得借款收到的现金245,0008,790,000--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计245,0008,790,000--
  偿还债务支付的现金-27,090,00027,090,00012,590,000
  分配股利、利润或偿付利息支付的现金51,705.0836,378,914.7936,369,020.6336,349,808.13
  支付其他与筹资活动有关的现金594,450901,404901,404-
  筹资活动现金流出小计646,155.0864,370,318.7964,360,424.6348,939,808.13
  筹资活动产生的现金流量净额-401,155.08-55,580,318.79-64,360,424.63-48,939,808.13
五、现金及现金等价物净增加额38,044,952.6-206,883,651.43-236,990,335.42-126,126,085.54
  加:期初现金及现金等价物余额97,094,952.86303,978,604.29303,978,604.29303,978,604.29
  期末现金及现金等价物余额135,139,905.4697,094,952.8666,988,268.87177,852,518.75
补充资料:
  净利润-236,929,075.58-97,785,465
  资产减值准备-4,023,580.81-1,181,992.82
  固定资产和投资性房地产折旧-25,815,556.91-13,072,590.29
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-25,815,556.91-13,072,590.29
  无形资产摊销-1,524,893.52-436,750.44
  长期待摊费用摊销-284,609.38-159,329.02
  处置固定资产、无形资产和其他长期资产的损失-26,532.78--
  固定资产报废损失-106,520.03-85,121.41
  公允价值变动损失--720,457.53--386,739.73
  财务费用-421,903.12-383,823.25
  投资损失--8,269,312.65--4,210,615.76
  递延所得税--2,786,367.95--140,446.1
  其中:递延所得税资产减少--2,640,546.07--66,510.42
    递延所得税负债增加--145,821.88--73,935.68
  存货的减少--16,807,802.23--943,905.42
  经营性应收项目的减少--132,502,292.03--102,912,402.98
  经营性应付项目的增加-47,677,864.34-23,334,268.48
  现金的期末余额-97,094,952.86-177,852,518.75
  减:现金的期初余额-303,978,604.29-303,978,604.29
  现金及现金等价物的净增加额--206,883,651.43--126,126,085.54
公告日期2026-04-282026-03-052025-10-302025-08-19
审计意见(境内)标准无保留意见
TOP↑